The second lncRNA, KLHDC7B-DT, has been studied previously in pancreatic ductal adenocarcinoma (57), where it was found to bind to the IL6 promoter region, and in psoriasis (58), where researchers showed a relationship between the lncRNA and ILF2, a T-cell-associated enhancer of the IL2 gene, with both genes being upregulated in lesional skin. Here, IL2 is linked to pancreatic ductal adenocarcinoma.